Journal profile · CLINICAL NEUROLOGY
Clinical Parkinsonism & Related Disorders
ISSN 2590-1125 · Elsevier
Clinical Parkinsonism & Related Disorders: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.7 (journal website); fully open access; APC about USD 2,780; median 85 days to acceptance (103 articles, last 24 months); 122 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Clinical Parkinsonism & Related Disorders is published by Elsevier and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments and Parkinson's Disease and Spinal Disorders, together about 53.4% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)
Clinical Parkinsonism & Related Disorders is an online-only, open access journal committed to publishing high-quality peer reviewed articles related to clinical aspects of movement disorders which broadly include phenomenology (interesting case/case series/rarities), investigative (for e.g. genetics, imaging), translational (phenotype-genotype or other) and treatment aspects (clinical guidelines, diagnostic and treatment algorithms). In addition, the journal encourages the publication of educative material (solicited and unsolicited reviews), clinical-pathological cases, drug trials result, and task force reports related to the field of movement disorders. The submission of multimedia material accompanying all types of articles is also encouraged.Clinical Parkinsonism & Related Disorders is a companion journal to Parkinsonism & Related Disorders.Clinical Parkinsonism & Related Disorders is affiliated with the International Association of Parkinsonism and Related Disorders.
From the journal's Aims & Scope
Research area (LetPub): CLINICAL NEUROLOGY
Editor-in-chief Huifang ShangPublisher website
Editorial board by country: 7 in mainland China (about 16%); most named United States 17, Mainland China 7, Singapore 5, Japan 2, India 2 (45 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Parkinson's Disease Mechanisms and TreatmentsMedicine28.2%
- Neurological disorders and treatmentsMedicine17.7%
- Parkinson's Disease and Spinal DisordersMedicine7.5%
- Balance, Gait, and Falls PreventionHealth Professions6.3%
- Botulinum Toxin and Related Neurological DisordersMedicine5%
- Voice and Speech DisordersMedicine4.9%
- Genetic Neurodegenerative DiseasesNeuroscience4.3%
- Transcranial Magnetic Stimulation StudiesNeuroscience2.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2.7Publisher website ·
- CiteScore 2026-06
- 2.7LetPub ·
- CiteScore (publisher)
- 2.7Publisher website ·
- SJR 2026-06
- 0.65LetPub ·
- SNIP 2026-06
- 0.83LetPub ·
- h-index
- 24OpenAlex ·
- i10-index
- 79OpenAlex ·
- 2-year mean citedness
- 1.49OpenAlex ·
- Self-citation rate
- 7.4%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 110LetPub ·
Articles by year OpenAlex count · 499 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 84 | 84 | 21 |
| 2025 | 122 | 122 | 154 |
| 2024 | 64 | 64 | 228 |
| 2023 | 49 | 49 | 365 |
| 2022 | 52 | 52 | 347 |
| 2021 | 41 | 41 | 450 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
85 daysMedian, submission to acceptance · P25–P75 60 days – 120 days
- Acceptance to online
- median 2 days (103 articles)
- Submission to online
- median 88 days
- Sample
- 103 articles with submission and acceptance dates (224 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 15 weeksLetPub ·
- Submission to first decision
- 4 daysPublisher website ·
- First decision after review
- 39 daysPublisher website ·
- Submission to acceptance
- 84 daysPublisher website ·
- Acceptance to publication
- 3 daysPublisher website ·
- Submission to publication (journal-reported)
- about 13 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,780 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 2,730 / EUR 2,550 / GBP 2,190 / JPY 338,600 | — | — | |
| LetPub | USD 2,400 | Yes | — | |
| Publisher website | USD 2,920 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Manuscript length
- ≤ 4,000 words
- Reference style
- Numbered, in order of citation
- Highlights
- Optional
- Graphical abstract
- Optional
Article types accepted8
- case reportReview Articles of specialized topics within the scope of the journal. All submissions are welcome; there is no need to ask permission to submit a Review Articl…Length not stated
- correspondenceReview Articles of specialized topics within the scope of the journal. All submissions are welcome; there is no need to ask permission to submit a Review Articl…Length not stated
- full-length articlesFull-length Articles reporting original results of research within the field of Parkinsonism and Related Disorders. The maximum length allowed will be 4,000 wor…Length not stated
- hypothesisReview Articles of specialized topics within the scope of the journal. All submissions are welcome; there is no need to ask permission to submit a Review Articl…Length not stated
- letters to the editorReview Articles of specialized topics within the scope of the journal. All submissions are welcome; there is no need to ask permission to submit a Review Articl…Length not stated
- review articleReview Articles of specialized topics within the scope of the journal. All submissions are welcome; there is no need to ask permission to submit a Review Articl…Length not stated
- short communicationReview Articles of specialized topics within the scope of the journal. All submissions are welcome; there is no need to ask permission to submit a Review Articl…Length not stated
- short communicationsShort Communications reporting on research that has progressed to the stage where preliminary publication is appropriate. The maximum length allowed will be 2,0…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
Publishing ethics policy Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- ISSN
- 2590-1125
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Clinical Parkinsonism & Related Disorders
What CAS zone is Clinical Parkinsonism & Related Disorders in?
In the 2025 upgraded edition of the CAS Journal Ranking, Clinical Parkinsonism & Related Disorders is in Zone 4 of Medicine, and in Zone 4 of the minor category Clinical Neurology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Clinical Parkinsonism & Related Disorders?
The journal's website gives an impact factor of 2.7; this is the journal's own figure, as LetPub lists none for it; CiteScore 2.7, h-index 24.
How long does peer review take at Clinical Parkinsonism & Related Disorders?
Based on the dates recorded on 103 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 85 days (interquartile range 60–120 days); authors report an average review time of about 15 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Clinical Parkinsonism & Related Disorders?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Manuscript length: ≤ 4,000 words; Reference style: Numbered, in order of citation; Highlights: Optional; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Clinical Parkinsonism & Related Disorders based?
Of the 45 board members whose country the journal's board page names, 7 (about 16%) are in mainland China; the countries named most often are United States (17), Mainland China (7) and Singapore (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Clinical Parkinsonism & Related Disorders?
According to LetPub and DOAJ records, Clinical Parkinsonism & Related Disorders is indexed in ESCI, Scopus and DOAJ.
Is Clinical Parkinsonism & Related Disorders open access, and what is the APC?
Clinical Parkinsonism & Related Disorders is a fully open-access journal. APC about USD 2,780.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .